Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 7 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2016 Filed Jan 4, 2017 20:39 UTC |
CRAWFORD CURTIS JDirector
|
GrantStock Units · Derivative | 589 | $21.22 | $12,498.58 |
DisclosureSEC source: 0001627223-17-000002 · primary_doc.xml · derivative · entry 3 CRAWFORD CURTIS J · CIK 0001014318 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,260 Underlying: Common Stock · 589 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · shares: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 20:17 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 1,060 | $21.22 | $22,493.20 |
DisclosureSEC source: 0001627223-17-000001 · primary_doc.xml · derivative · entry 2 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,998 Underlying: Common Stock · 1,060 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · shares: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 21:47 UTC |
Newman MarkSenior VP and CFO
|
Tax withholdingCommon Stock | 10,544 | $20.71 | $218,366.24 |
DisclosureSEC source: 0001627223-16-000149 · primary_doc.xml · nonDerivative · entry 1 Newman Mark · CIK 0001524597 · Senior VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,738 F1 · shares: Taxes withheld on vested restricted stock units and dividend equivalent units. F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| October 27, 2016 Filed Oct 31, 2016 21:22 UTC |
Albright ElizabethSr. VP - Human Resources
|
Tax withholdingCommon Stock | 8,445 | $16.90 | $142,720.50 |
DisclosureSEC source: 0001627223-16-000144 · primary_doc.xml · nonDerivative · entry 1 Albright Elizabeth · CIK 0001645197 · Sr. VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,351 F1 · shares: Taxes withheld on vested restricted stock units (RSUs) and dividend equivalent units (DEUs). F2 · balance_after: Includes directly owned shares, unvested RSUs and DEUs. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 16:42 UTC |
CRAWFORD CURTIS JDirector
|
GrantStock Units · Derivative | 781.25 | $16.00 | $12,500.00 |
DisclosureSEC source: 0001627223-16-000142 · primary_doc.xml · derivative · entry 3 CRAWFORD CURTIS J · CIK 0001014318 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,670.8 Underlying: Common Stock · 781.25 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · shares: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. F4 · balance_after: Includes stock units and dividend equivalent units. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 17:13 UTC |
BROWN RICHARD HDirector
|
GrantStock Units · Derivative | 1,406.25 | $16.00 | $22,500.00 |
DisclosureSEC source: 0001627223-16-000143 · primary_doc.xml · derivative · entry 2 BROWN RICHARD H · CIK 0001120652 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,937.96 Underlying: Common Stock · 1,406.25 shares Expires not disclosed F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F2 · shares: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock. F3 · derivative.exercise_date: Payable upon separation from service. F3 · derivative.expiration_date: Payable upon separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.